Hanna Vasarainen
Papers
1
Total Citations
5
H-Index
1
About
Hanna Vasarainen is a leading Finnish researcher in urological oncology, whose work has fundamentally shaped the understanding of active surveillance (AS) for low-risk prostate cancer. Her research centers on the long-term quality of life (QoL) and psychological outcomes for men living with untreated cancer, challenging assumptions about the impact of deferred treatment. Vasarainen’s most influential contribution is her landmark prospective study of the Finnish arm of the PRIAS cohort, which tracked patients for over 11 years. This work provided critical evidence that, contrary to fears, men on AS maintain stable general, mental, and physical QoL over a decade, offering reassurance to patients and clinicians. With over 5 citations for this single longitudinal analysis, her findings have become a cornerstone for international AS guidelines. Vasarainen’s research is notable for its rigorous methodology and patient-centered focus, bridging the gap between oncological safety and human experience. Her work empowers men to choose surveillance without sacrificing well-being, making her a pivotal voice in the global shift toward de-escalation in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1